Cortisol Serum Levels and their Relationship to Certain Antiretroviral Drugs

References

• Christeff N, Gharakhanian S, Thobie N, Rozenbaum W, Nunez EA. Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr 1992; 5: 841–6.
   PubMed Web of Science ®Google Scholar
• Villette JM, Bourin P, Doinel C, Mansour I, Fiet J, Boudou P, et al. Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metab 1990; 70: 572–7.
   PubMed Web of Science ®Google Scholar
• Verges B, Chavanet P, Desgres J, Vaillant G, Waldner A, Brun JM, Putelat R. Adrenal function in HIV infected patients. Acta Endocrinol (Copenh) 1989; 121: 633–7.
   PubMedGoogle Scholar
• Membreno L, Irony I, Dere W, Klein R, Biglieri EG, Cobb E. Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1987; 65: 482–7.
   PubMed Web of Science ®Google Scholar
• Mayo J, Collazos J, Martínez E, Ibarra S. Adrenal function in the human immunodeficiency virus-infected patient. Arch Intern Med 2002; 162: 1095–8.
   Google Scholar
• Christeff N, Gherbi N, Mammes O, Dalle MT, Gharakhanian S, Lortholary O, et al. Serum cortisol and DHEA concentrations. Psychoneuroendocrinology 1997; 22(Suppl 1): S11–8.
   Web of Science ®Google Scholar
• Clerici M, Bevilacqua M, Vago T, Villa ML, Shearer GM, Norbiato G. An immunoendocrinological hypothesis of HIV infection. Lancet 1994; 343: 1552–3.
   PubMed Web of Science ®Google Scholar
• Leserman J, Petitto JM, Gu H, Gaynes BN, Barroso J, Golden RN, et al. Progession to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med 2002; 32: 1059–73.
   PubMed Web of Science ®Google Scholar
• Clerici M, Trabattoni D, Piconi S, Fusi ML, Ruzzante S, Clerici C, Villa ML. A possible role for the cortisol anticortisol imbalance in the progression of human immunodeficiency virus. Psychoneuroendocrinology 1997; 22(Suppl 1): S27–31.
   Google Scholar
• Christeff N, Melchior JC, de Truchis P, Perronne C, Nunez EA, Gougeon ML. Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations. AIDS 1999; 13: 2251–60.
   PubMed Web of Science ®Google Scholar
• Collazos J, Mayo J, Martínez E, Ibarra S. Serum cortisol in HIV-infected patients with and without highly active antiretroviral therapy. AIDS 2003; 17: 123–6.
   Google Scholar
• Yanovski JA, Miller KD, Kino T, Friedman TC, Chrousos GP, Tsigos C, Falloon J. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy. J Clin Endocrinol Metab 1999; 84: 1925–31.
   Google Scholar
• Saint-Marc T, Partisani M, Poizot-Martin I, Bruno F, Rouviere O, Lang JM, et al. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS 1999; 13: 1659–67.
   Google Scholar
• Inaba T, Fischer NE, Riddick DS, Stewart DJ, Hidaka T. HIV protease inhibitors saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzox-azinorifamycin, KRM-1648, in human liver microsomes. Toxicol Lett 1997; 93: 215–9.
   Google Scholar
• Ruiz N. Clinical history of efavirenz. Int J Clin Pract (Suppl) 1999; 103: 3–7.
   Google Scholar
• Barry M, Mulcahy F, Merry C, Gibbons S, Back D. Pharmacokinetics and potential interactions among antiretroviral agents used to treat patients with HIV infection. Clin Pharmacokinet 1999; 36: 289–304.
   Google Scholar
• Clarke SM, Mulcahy FM, Tjia J, Reynolds HE, Gibbons SE, Barry MG, Back DJ. The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz. Br J Clin Pharmacol 2001; 51: 213–7.
   Google Scholar
• Fichtenbaum CJ, Gerber JG. Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection. Clin Pharmacokinet 2002; 41: 1195–211.
   PubMed Web of Science ®Google Scholar
• Collazos J, Mayo J, Martínez E, Ibarra S. Association between sexual disturbances and sexual hormones with specific antiretroviral drugs. AIDS 2002; 16: 1294–5.
   Google Scholar
• Bureik M, Lisurek M, Bernhardt R. The human steroid hydroxylases CYP11B1 and CYP11B2. Biol Chem 2002; 383: 1537–51.
   Google Scholar
• Abel SM, Maggs JL, Back DJ, Park BK. Cortisol metabolism by human liver in vitro. I. Metabolite identification and interindividual variability. J Steroid Biochem Mol Biol 1992; 43: 713–9.
   PubMed Web of Science ®Google Scholar
• Inagaki K, Inagaki M, Kataoka T, Sekido I, Gill MA, Nishida M. A wide inter-individual variability of urinary 6beta-hydroxycortisol to free cortisol in 487 healthy Japanese sub jects in near basal condition. Ther Drug Monit 2002; 24: 722–7.
   PubMed Web of Science ®Google Scholar
• Ohno M, Yamaguchi I, Ito T, Saiki K, Yamamoto I, Azuma J. Circadian variation of the urinary 6beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity. Eur J Clin Pharmacol 2000; 55: 861–5.
   PubMed Web of Science ®Google Scholar
• Abel SM, Back DJ, Maggs JL, Park BK. Cortisol metabolism in vitro. II. Species difference. J Steroid Biochem Mol Biol 1993; 45: 445–53.
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, et al. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 1990; 38: 207–13.
   PubMed Web of Science ®Google Scholar
• Gass RJ, Gal J, Fogle PW, Detmar-Hanna D, Gerber JG. Neither dapsone hydroxylation nor cortisol 6beta-hydroxylation detects the inhibition of CYP3A4 by HIV-1 protease inhibitors. Eur J Clin Pharmacol 1998; 54: 741–7.
   Google Scholar
• Mouly S, Lown KS, Kornhauser D, Joseph JL, Fiske WD, Benedek IH, Watkins PB. Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans. Clin Pharmacol Ther 2002; 72: 1–9.
   Google Scholar
• Hesse LM, von Moltke LL, Shader RI, Greenblatt DJ. Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion. Drug Metab Dispos 2001; 29: 100–2.
   PubMed Web of Science ®Google Scholar
• von Moltke LL, Greenblatt DJ, Granda BW, Giancarlo GM, Duan SX, Daily JP, et al. Inhibition of human cytochrome P450 isoforms by non-nucleoside reverse transcriptase inhibitors. J Clin Pharmacol 2001; 41: 85–91.
   PubMed Web of Science ®Google Scholar